Table 2.
Data for clinical efficacy between baseline and follow-up (12 month) and secondary outcomes both in conservative and surgical treatments
| Time/measure | Baseline mean (SE) | 12 month mean (SE) | Difference between groups in change from baseline (95% CI) | P valuec |
|---|---|---|---|---|
| VAS pain (score) | ||||
| Conservative group (n = 123) | 3.94 (2.60) | 1.50 (2.01) | −2.447 (−3.031 to −1.864) | <0.0001 |
| Surgical group (n = 95) | 3.40 (2.63) | 1.16 (1.66) | −2.235 (−2.867 to −1.603) | <0.0001 |
| MMO (mm) | ||||
| Conservative group (n = 123) | 33.31 (7.19) | 39.12 (5.05) | 5.813 (4.732 to 6.894) | <0.0001 |
| Surgical group (n = 95) | 33.19 (7.83) | 38.66 (5.03) | 5.474 (3.753 to 7.195) | <0.0001 |
| Masticatory ability (score) | ||||
| Conservative group (n = 88) | 1.53 (0.93) | 1.15 (0.80) | −0.4250 (−0.6718 to −0.1782) | 0.0008 |
| Surgical group (n = 68) | 1.71 (0.99) | 1.15 (0.87) | −0.5902 (−0.8923 to −0.2881) | 0.0002 |
MMO, maximum mouth opening; VAS, Visual Analogue Scale; *, P valuec < 0.05.